إعلان
إعلان
SNTI
Senti Biosciences, Inc. Common Stock
1.11
USDبرعاية
+0.03
+2.78%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
1.13
+0.01
+1.35%
تقارير أرباح SNTI
النسبة الإيجابية المفاجئة
SNTI تفوق 7 من 8 آخر التقديرات.
88%
التقرير التالي
بيانات التقرير القادم
١٨ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$680.00K
/-$0.42
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-39.13%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-37.31%
Senti Biosciences, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, SNTI reported earnings of -0.69 USD per share (EPS) for Q3 25, missing the estimate of -0.57 USD, resulting in a -19.38% surprise. Revenue reached --, compared to an expected 170.00 ألف, with a -100.00% difference. The market reacted with a -10.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.42 USD, with revenue projected to reach 680.00 ألف USD, implying an نقصان of -39.13% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
What were Senti Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Senti Biosciences, Inc. Common Stock reported EPS of -$0.69, missing estimates by -19.38%, and revenue of $0.00, -100% below expectations.
How did the market react to Senti Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -10.06%, changed from $1.79 before the earnings release to $1.61 the day after.
When is Senti Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٨ مارس ٢٠٢٦.
What are the forecasts for Senti Biosciences, Inc. Common Stock's next earnings report?
Based on 6
المحللين, Senti Biosciences, Inc. Common Stock is expected to report EPS of -$0.42 and revenue of $680.00K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان